scholarly article | Q13442814 |
P2093 | author name string | M A Horwitz | |
T F Byrd | |||
P2860 | cites work | Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron | Q34571751 |
Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages | Q36205312 | ||
Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts | Q36209351 | ||
Antimalarials increase vesicle pH in Plasmodium falciparum | Q36213878 | ||
Deferoxamine inhibition of malaria is independent of host iron status | Q36355145 | ||
Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes | Q37027949 | ||
Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol | Q37407350 | ||
pH and the recycling of transferrin during receptor-mediated endocytosis | Q37609089 | ||
The Effect of pH upon Human Transferrin: Selective Labelling of the Two Iron-binding Sites | Q39080353 | ||
Low molecular weight intracellular iron transport compounds | Q39634380 | ||
Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum | Q39663518 | ||
Difference between the two iron-binding sites of transferrin | Q40318488 | ||
Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels | Q40972345 | ||
Inhibition of hemoglobin degradation in Plasmodium falciparum by chloroquine and ammonium chloride | Q41913007 | ||
The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. | Q41914098 | ||
A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum | Q41915834 | ||
Chloroquine reduces neuronal and glial iron uptake | Q41915862 | ||
Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide | Q41916319 | ||
The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes | Q41920909 | ||
Pharmacologic actions of 4-aminoquinoline compounds | Q41921024 | ||
The effect of lysosomotrophic bases and inhibitors of transglutaminase on iron uptake by immature erythroid cells | Q41921516 | ||
Chloroquine: mode of action | Q41942231 | ||
Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine | Q41946261 | ||
The kinetics and mechanism of iron(3) exchange between chelates and transferrin. IV. The reaction of transferrin with iron(3) nitrilotriacetate. | Q44399118 | ||
A protein on Plasmodium falciparum-infected erythrocytes functions as a transferrin receptor | Q47907949 | ||
A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron. | Q47918674 | ||
Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. | Q47986167 | ||
Transferrin protein and iron uptake by cultured rat fibroblasts | Q66980401 | ||
Transferrin receptors and transferrin iron uptake by cultured human blood monocytes | Q69212363 | ||
Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization | Q70104476 | ||
Plasmodium falciparum takes up iron from transferrin | Q70380208 | ||
Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells | Q72883390 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chloroquine | Q422438 |
Legionella pneumophila | Q147885 | ||
P304 | page(s) | 351-357 | |
P577 | publication date | 1991-07-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens | |
P478 | volume | 88 |
Q34543802 | Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin |
Q21144279 | Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America |
Q41921243 | Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy |
Q62485394 | Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication |
Q39783540 | Bafilomycin A1 and intracellular multiplication of Legionella pneumophila. |
Q34022942 | Chloroquine and the fungal phagosome |
Q34137889 | Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis |
Q28379104 | Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation |
Q41945512 | Chloroquine inhibits Paracoccidioides brasiliensis survival within human monocytes by limiting the availability of intracellular iron. |
Q38773638 | Chloroquine inhibits Rhodococcus equi replication in murine and foal alveolar macrophages by iron-starvation |
Q39807701 | Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells |
Q28295002 | Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages |
Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
Q33750450 | Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases |
Q40946519 | Differential effects of iron load on basal and interferon-gamma plus lipopolysaccharide enhance anticryptococcal activity by the murine microglial cell line BV-2. |
Q39297927 | Differential modulation of intracellular survival of cytosolic and vacuolar pathogens by curcumin |
Q41924459 | Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages. |
Q34111734 | Effects of Anaplasma phagocytophilum on host cell ferritin mRNA and protein levels |
Q33973620 | Effects of chloroquine on viral infections: an old drug against today's diseases? |
Q37699548 | Efficacy of Resistance to Francisella Imparted by ITY/NRAMP/SLC11A1 Depends on Route of Infection |
Q40482171 | Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model. |
Q28379521 | Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis |
Q37191367 | Francisella tularensis phagosomal escape does not require acidification of the phagosome |
Q40515410 | Fungistatic effect of hydroxychloroquine, lessons from a case |
Q37894136 | Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron |
Q35403392 | Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth |
Q35603383 | Identification of TonB homologs in the family Enterobacteriaceae and evidence for conservation of TonB-dependent energy transduction complexes |
Q41709348 | In vitro Synergism between Chloroquine and Antibiotics against Orientia tsutsugamushi |
Q43017359 | In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi. |
Q59332950 | Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer |
Q35117471 | Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine |
Q33982070 | Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines. |
Q99624086 | Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 |
Q37157743 | Iron in innate immunity: starve the invaders |
Q36973431 | Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D |
Q34132560 | Legionella pneumophila feoAB promotes ferrous iron uptake and intracellular infection |
Q36369087 | Legionella pneumophila replication vacuoles mature into acidic, endocytic organelles |
Q41927309 | Lysosomotropic agents ameliorate macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: a role for lipid peroxidation |
Q35838651 | Manipulation of iron to determine survival: competition between host and pathogen |
Q40501308 | Measuring the pH of pathogen-containing phagosomes. |
Q90227080 | Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells |
Q33863078 | Modulation of intramacrophage iron metabolism during microbial cell invasion |
Q46944310 | Monitoring lactoferrin iron levels by fluorescence resonance energy transfer: a combined chemical and computational study |
Q73009316 | Polyvalent cationic metals induce the rate of transferrin-independent iron acquisition by HL-60 cells |
Q40472009 | Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. |
Q37439277 | Quantitative assessment of cytosolic Salmonella in epithelial cells. |
Q24799086 | Quinine sulfate and bacterial invasion |
Q36880738 | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century |
Q33893144 | Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma |
Q34113689 | Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae |
Q35689020 | Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice |
Q40724076 | Role of cytokines in tuberculosis |
Q51694459 | Severe Legionella pneumophila pneumonia in a patient with iron overload. |
Q35668833 | Strategies of Intracellular Pathogens for Obtaining Iron from the Environment |
Q35632820 | Superinfection in malaria: Plasmodium shows its iron will |
Q39397002 | The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages |
Q34003442 | The Legionella pneumophila iraAB locus is required for iron assimilation, intracellular infection, and virulence |
Q31884593 | The anti-HIV-1 activity of chloroquine |
Q28485637 | The major iron-containing protein of Legionella pneumophila is an aconitase homologous with the human iron-responsive element-binding protein |
Q37367708 | Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes |
Q94465279 | Will the antimalarial drug take over to combat COVID-19? |
Q38196348 | Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer |
Search more.